Dima Shulkin: A Novel Monocyte-Based Biomarker of Cardiovascular Risk
Dima Shulkin, Co-Founder and CTO at RobotDreams GmbH, shared a post on LinkedIn:
“What if a simple blood test could flag hidden heart disease long before any symptoms appear?
A 2024 medRxiv preprint by Almarri and colleagues (not yet peer-reviewed) explored exactly that.
They studied symptom-free adults, first a small group of 39, then 151 more in Nanjing, China, measuring immune cells called monocytes (part of the body’s defense team) and how often they clump with platelets.
The readings became a new score, MARS, which tracked real artery damage far more closely than the standard risk calculators doctors use now.
Early research, but a real hint that a blood sample may reveal what checklists miss.”
Other posts featuring Dima Shulkin on Hemostasis Today.
-
Aug 31, 2026, 05:35Does LDL Cholesterol Influence VTE Risk? – Ordo Fraterna Fibonacci
-
Aug 31, 2026, 05:19Tania Ahuja: Apixaban in Abdominal Transplant Patients
-
Aug 31, 2026, 04:28Reza Hafidz Irawan։ Automated Antibody Titration With Erytra Eflexis
-
Aug 31, 2026, 04:17Safa Chenganath: Stenosis vs Thrombosis – Hemodialysis Vascular Access
-
Aug 30, 2026, 17:13J. Meireles-Brandao: Hypertension, Inflammation and Lipoprotein Disease
-
Aug 30, 2026, 17:10Hugh Nguyen: Leading the New Era of Blood Services Across Asia Pacific
-
Aug 30, 2026, 17:09Transforming Childhood Through Access to Hemophilia Treatment – World Federation of Hemophilia
-
Aug 30, 2026, 17:07Raj Bharath: Connecting Clinicians and Researchers to Advance Transfusion Medicine
-
Aug 30, 2026, 17:04Rana Al Hrout: Free FRCPath Haematology Part 1 Exam Preparation Session